These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6520830)

  • 1. Dose, plasma concentration and response relationships of D-penicillamine in patients with rheumatoid arthritis.
    Brooks PM; Miners JO; Smith K; Smith MD; Fearnley I; Birkett DJ
    J Rheumatol; 1984 Dec; 11(6):772-5. PubMed ID: 6520830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the major metabolites of D-penicillamine in patients with rheumatoid arthritis.
    Carruthers G; Harth M; Freeman D; Weir D; Rothwell R; Butler M
    Clin Invest Med; 1984; 7(1):35-40. PubMed ID: 6723122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of D-penicillamine in patients with rheumatoid arthritis undergoing hemodialysis.
    Matthey F; Perrett D; Greenwood RN; Baker LR
    Clin Nephrol; 1986 May; 25(5):268-71. PubMed ID: 3720037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum histidine in rheumatoid arthritis: changes induced by antirheumatic drug therapy.
    Pickup ME; Dixon JS; Lowe JR; Wright V
    J Rheumatol; 1980; 7(1):71-6. PubMed ID: 7354471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for assaying D-penicillamine in a clinical setting.
    Crawhall JC
    Clin Invest Med; 1984; 7(1):31-4. PubMed ID: 6723121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interactions of penicillamine in rheumatoid arthritis.
    Seideman P; Lindström B
    J Rheumatol; 1989 Apr; 16(4):473-4. PubMed ID: 2664169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Side effects of d-penicillamine in the treatment of rheumatoid arthritis].
    Mazzanti G; Paladini G; Damiani D; Bianchini D; Florean M; Mesesnel E; Cataldo R
    Minerva Med; 1986 May; 77(22-23):1009-16. PubMed ID: 2941698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent treatment with D-penicillamine is effective in lower doses and with fewer adverse effects in patients with rheumatoid arthritis.
    Hakoda M; Taniguchi A; Kamatani N; Akahoshi T; Kashiwazaki S
    J Rheumatol; 1994 Sep; 21(9):1637-41. PubMed ID: 7799341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent induction of insulin autoantibodies by D-penicillamine in patients with rheumatoid arthritis.
    Vardi P; Brik R; Barzilai D; Lorber M; Scharf Y
    J Rheumatol; 1992 Oct; 19(10):1527-30. PubMed ID: 1464863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tiopronine: new basic treatment for rheumatoid arthritis. Open study of 158 cases].
    Pasero G; Pellegrini P; Ciompi ML; Colamussi V; Barbieri P; Mazzoni MR
    Rev Rhum Mal Osteoartic; 1980 Mar; 47(3):163-8. PubMed ID: 7384725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic studies of D-penicillamine in the treatment of rheumatoid arthritis.
    Payne RW; Cahill CL
    J Okla State Med Assoc; 1969 Oct; 62(10):487-91. PubMed ID: 5406880
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitoring of patients with rheumatoid arthritis in longterm administration of D-penicillamine.
    Dominkus M; Chlud K; Maida EM; Grisold W
    J Rheumatol; 1992 Oct; 19(10):1648-50. PubMed ID: 1464886
    [No Abstract]   [Full Text] [Related]  

  • 13. [D-penicillamine--a current review of areas of use and dosage guidelines].
    Sörensen H
    Z Rheumatol; 1988; 47 Suppl 1():13-6. PubMed ID: 3063002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilia in rheumatoid patients treated with D-penicillamine.
    Edelman J; Maguire KF; Owen ET
    J Rheumatol; 1984 Oct; 11(5):624-5. PubMed ID: 6512792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [5-year treatment of rheumatoid polyarthritis with D-penicillamine].
    Duquesnoy B; Cocheteux P; Siame JL; Delcambre B
    Sem Hop; 1983 May; 59(21):1641-4. PubMed ID: 6310780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [D-penicillamine in the treatment of rheumatoid arthritis].
    Gerloni V; Colombo B; Carraière G
    Reumatismo; 1977; 29(2-3):157-62. PubMed ID: 616962
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood levels and side-effects of D-penicillamine.
    Van Der Korst JK; Muijsers AO; Henrichs AM; Ament HJ; Van De Stadt RJ
    Agents Actions Suppl; 1979; (5):159-67. PubMed ID: 294133
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term use of D-penicillamine in systemic scleroderma and rheumatoid arthritis].
    Guseva NG; Trofimova TM; Oskilko TG; Panasiuk AF; Tarasenkova TA
    Klin Med (Mosk); 1986 Jun; 64(6):44-50. PubMed ID: 3747436
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antibodies to D-penicillamine in patients with chronic polyarthritis--diagnostic aid in undesired and insufficient drug effects?].
    Storch W; Keitel W
    Z Rheumatol; 1988; 47 Suppl 1():44-7. PubMed ID: 3213272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of D-penicillamine on plasma amino acids in rheumatoid arthritis.
    Partsch G; Tausch G; Neuwirth E; Neumüller J
    Z Rheumatol; 1983; 42(3):126-9. PubMed ID: 6880413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.